[{"indications": "Indications\u00a0see under preparations", "name": "PROGESTERONE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.4 Sex hormones", "6.4.1 Female sex hormones", "6.4.1.2 Progestogens", "PROGESTERONE"], "cautions": "Cautions\u00a0\n(From 6.4.1.2 Progestogens: British National Formulary)\nCautions\u00a0Progestogens should be used with caution in conditions that may worsen with fluid retention e.g. epilepsy, hypertension, migraine, asthma, or cardiac dysfunction, and in those susceptible to thromboembolism (particular caution with high dose). Care is also required in those with a history of depression. Progestogens can decrease glucose tolerance and patients with diabetes should be monitored closely. For interactions see Appendix 1 (progestogens).", "side-effects": "Side-effects\u00a0see notes above; injection-site reactions; pain,\r\ndiarrhoea and flatulence can occur with rectal administration", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4359.htm", "doses": ["See under preparations", "by deep intramuscular injection into buttock,\r\ndysfunctional uterine bleeding, 5\u201310\u00a0mg daily for 5\u201310 days until\r\n2 days before expected onset of menstruation"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}]